Literature DB >> 7494795

Characterization of alkylating versus intercalating anticancer drug-induced effects on cell survival, cell cycle kinetic and morphonuclear pattern of three neoplastic cells lines growing in vitro.

O Pauwels1, R Kiss, J L Pasteels, G Atassi.   

Abstract

PURPOSE: The influence of three alkylating and three intercalating anticancer drugs on cell survival, cell cycle kinetics and chromatin patterns was monitored in vitro on three neoplastic cell lines.
METHODS: This monitoring was carried out by means of the digital cell image analysis of Feulgen-stained nuclei.
RESULTS: Results show that in term of cytotoxicity, the intercalating drugs were more potent than the alkylating ones. As for the cell kinetics assessment, most of the experimental conditions led to a blockage of the cells in the G2 phase of the cell cycle. A study of chromatin patterns by means of digital cell image analysis enabled us to describe 15 morphonuclear parameters. The results show that the drugs tested induced specific morphonuclear modifications, e.g. an increase in nuclear size. The 15 morphonuclear parameters were submitted to multivariate analyses, i.e. principal-components analyses followed by the canonical transformation of the data. The results of these multivariate analyses enabled us to discriminate between the alkylating and the intercalating drugs.
CONCLUSIONS: We conclude that it would be possible to "diagnose" the mechanism of action of DNA interacting agents (alkylating or intercalating drugs) by means of the combination of digital cell image and multivariate analysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494795     DOI: 10.1023/a:1016258431063

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  Estrogen receptor characterization in a transplantable mouse mammary tumor.

Authors:  C Watson; D Medina; J H Clark
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

2.  Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

Authors:  J Bubeník; M Baresová; V Viklický; J Jakoubková; H Sainerová; J Donner
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

Review 3.  DNA modification and cancer.

Authors:  M J Waring
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

4.  Combination of computerized morphonuclear and multivariate analyses to characterize in vitro the antineoplastic effect of alkylating agents.

Authors:  O Pauwels; G Atassi; R Kiss
Journal:  J Pharmacol Toxicol Methods       Date:  1995-02       Impact factor: 1.950

5.  Computer-assisted microscope analysis of morphonuclear modifications induced by anticancer antimetabolites in cell lines cultured in vitro.

Authors:  O Pauwels; R Kiss; G Atassi
Journal:  Anticancer Drugs       Date:  1994-04       Impact factor: 2.248

Review 6.  Intercalating drugs: DNA binding and molecular pharmacology.

Authors:  W D Wilson; R L Jones
Journal:  Adv Pharmacol Chemother       Date:  1981

7.  Numerical evaluation of cytologic data. V. Bivariate distributions and the Bayesian decision Boundary.

Authors:  P H Bartels
Journal:  Anal Quant Cytol       Date:  1980-06

8.  Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor regression.

Authors:  M Briffod; F Spyratos; M Tubiana-Hulin; C Pallud; C Mayras; A Filleul; J Rouëssé
Journal:  Cancer       Date:  1989-02-15       Impact factor: 6.860

9.  Digital cell image analysis of verapamil-induced effects in chemosensitive and chemoresistant neoplastic cell lines.

Authors:  C Etiévant; O Pauwels; R Kiss
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

10.  Doxorubicin inhibits human DNA topoisomerase I.

Authors:  P D Foglesong; C Reckord; S Swink
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.